| Year |
Citation |
Score |
| 2023 |
Gaines T, Garcia F, Virani S, Liang Z, Yoon Y, Oum YH, Shim H, Mooring SR. Corrigendum to "Synthesis and evaluation of 2,5-furan, 2,5-thiophene and 3,4-thiophene-based derivatives as CXCR4 inhibitors" [Eur. J. Med. Chem. 181 (2019) 111562]. European Journal of Medicinal Chemistry. 115753. PMID 37634992 DOI: 10.1016/j.ejmech.2023.115753 |
0.725 |
|
| 2019 |
Gaines T, Garcia F, Virani S, Liang Z, Yoon Y, Oum YH, Shim H, Mooring SR. Synthesis and evaluation of 2,5-furan, 2,5-thiophene and 3,4-thiophene-based derivatives as CXCR4 inhibitors. European Journal of Medicinal Chemistry. 181: 111562. PMID 31377592 DOI: 10.1016/J.Ejmech.2019.111562 |
0.752 |
|
| 2019 |
Rocabado GA, Kilpatrick NA, Mooring SR, Lewis JE. Can We Compare Attitude Scores among Diverse Populations? An Exploration of Measurement Invariance Testing to Support Valid Comparisons between Black Female Students and Their Peers in an Organic Chemistry Course Journal of Chemical Education. 96: 2371-2382. DOI: 10.1021/Acs.Jchemed.9B00516 |
0.389 |
|
| 2018 |
Virani S, Liang Z, Yoon Y, Shim H, Mooring SR. Synthesis and evaluation of 2,5-diamino and 2,5-dianilinomethyl pyridine analogues as potential CXCR4 antagonists. Bioorganic & Medicinal Chemistry Letters. PMID 30514601 DOI: 10.1016/J.Bmcl.2018.11.052 |
0.469 |
|
| 2017 |
Burrows NL, Nowak MK, Mooring SR. Students’ perceptions of a project-based Organic Chemistry laboratory environment: a phenomenographic approach Chemistry Education Research and Practice. 18: 811-824. DOI: 10.1039/C7Rp00064B |
0.714 |
|
| 2016 |
Gaines T, Camp D, Bai R, Liang Z, Yoon Y, Shim H, Mooring SR. Synthesis and evaluation of 2,5 and 2,6 pyridine-based CXCR4 inhibitors. Bioorganic & Medicinal Chemistry. PMID 27576294 DOI: 10.1016/J.Bmc.2016.08.018 |
0.756 |
|
| 2016 |
Bai R, Liang Z, Yoon Y, Liu S, Gaines T, Oum Y, Shi Q, Mooring SR, Shim H. Symmetrical bis-tertiary amines as novel CXCR4 inhibitors. European Journal of Medicinal Chemistry. 118: 340-350. PMID 27179215 DOI: 10.1016/J.Ejmech.2016.04.040 |
0.756 |
|
| 2016 |
Mooring SR, Mitchell CE, Burrows NL. Evaluation of a Flipped, Large-Enrollment Organic Chemistry Course on Student Attitude and Achievement Journal of Chemical Education. 93: 1972-1983. DOI: 10.1021/Acs.Jchemed.6B00367 |
0.714 |
|
| 2015 |
Burrows NL, Mooring SR. Using concept mapping to uncover students' knowledge structures of chemical bonding concepts Chemistry Education Research and Practice. 16: 53-66. DOI: 10.1039/C4Rp00180J |
0.708 |
|
| 2014 |
Mooring SR, Gaines T, Liang Z, Shim H. Synthesis of pyridine derivatives as potential antagonists of chemokine receptor type 4. Heterocyclic Communications. 20: 149-153. PMID 25620839 DOI: 10.1515/hc-2014-0041 |
0.755 |
|
| 2013 |
Mooring SR, Liu J, Liang Z, Ahn J, Hong S, Yoon Y, Snyder JP, Shim H. Benzenesulfonamides: a unique class of chemokine receptor type 4 inhibitors. Chemmedchem. 8: 622-32. PMID 23468189 DOI: 10.1002/Cmdc.201200582 |
0.458 |
|
| 2012 |
Shi Q, Yin S, Kaluz S, Ni N, Devi NS, Mun J, Wang D, Damera K, Chen W, Burroughs S, Mooring SR, Goodman MM, Van Meir EG, Wang B, Snyder JP. Binding Model for the Interaction of Anticancer Arylsulfonamides with the p300 Transcription Cofactor. Acs Medicinal Chemistry Letters. 3: 620-5. PMID 24936238 DOI: 10.1021/Ml300042K |
0.673 |
|
| 2011 |
Mooring SR, Jin H, Devi NS, Jabbar AA, Kaluz S, Liu Y, Van Meir EG, Wang B. Design and synthesis of novel small-molecule inhibitors of the hypoxia inducible factor pathway. Journal of Medicinal Chemistry. 54: 8471-89. PMID 22032632 DOI: 10.1021/Jm201018G |
0.596 |
|
| 2011 |
Tan C, de Noronha RG, Devi NS, Jabbar AA, Kaluz S, Liu Y, Mooring SR, Nicolaou KC, Wang B, Van Meir EG. Sulfonamides as a new scaffold for hypoxia inducible factor pathway inhibitors. Bioorganic & Medicinal Chemistry Letters. 21: 5528-32. PMID 21831638 DOI: 10.1016/J.Bmcl.2011.06.099 |
0.554 |
|
| 2011 |
Mooring SR, Wang B. HIF-1 inhibitors as anti-cancer therapy Science China Chemistry. 54: 24-30. DOI: 10.1007/S11426-010-4187-5 |
0.506 |
|
| Show low-probability matches. |